FDA panel recommends limiting Pfizer booster shots to Americans 65 and older, and those at high risk of severe COVID-19
- Written by Matthew Woodruff, Instructor of Human Immunology, Emory University

The key scientific advisory council of the Food and Drug Administration has voted to deny use of a “booster” shot of Pfizer’s mRNA vaccine to the general public – a move that will likely disappoint some public health experts pushing for a third dose to help slow the spread of...